Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 3
1989 2
1990 2
1991 1
1992 3
1993 8
1994 2
1995 5
1996 3
1997 5
1998 4
1999 7
2000 6
2001 3
2002 4
2003 8
2004 7
2005 11
2006 10
2007 13
2008 7
2009 6
2010 13
2011 13
2012 6
2013 11
2014 10
2015 13
2016 10
2017 19
2018 14
2019 13
2020 14
2021 20
2022 12
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Results by year

Filters applied: . Clear all
Page 1
Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Rageth CJ, O'Flynn EAM, Pinker K, Kubik-Huch RA, Mundinger A, Decker T, Tausch C, Dammann F, Baltzer PA, Fallenberg EM, Foschini MP, Dellas S, Knauer M, Malhaire C, Sonnenschein M, Boos A, Morris E, Varga Z. Rageth CJ, et al. Among authors: foschini mp. Breast Cancer Res Treat. 2019 Apr;174(2):279-296. doi: 10.1007/s10549-018-05071-1. Epub 2018 Nov 30. Breast Cancer Res Treat. 2019. PMID: 30506111 Free PMC article. Review.
Breast lesions with myoepithelial phenotype.
Foschini MP, Nishimura R, Fabbri VP, Varga Z, Kaya H, Cserni G. Foschini MP, et al. Histopathology. 2023 Jan;82(1):53-69. doi: 10.1111/his.14826. Histopathology. 2023. PMID: 36482278 Review.
IRF2BPL as a novel causative gene for progressive myoclonus epilepsy.
Gardella E, Michelucci R, Christensen HM, Fenger CD, Reale C, Riguzzi P, Pasini E, Albini-Riccioli L, Papa V, Foschini MP, Cenacchi G, Furia F, Marjanovic D, Hammer TB, Møller RS, Rubboli G. Gardella E, et al. Among authors: foschini mp. Epilepsia. 2023 Aug;64(8):e170-e176. doi: 10.1111/epi.17634. Epub 2023 Jun 8. Epilepsia. 2023. PMID: 37114479
Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis.
Cserni G, Quinn CM, Foschini MP, Bianchi S, Callagy G, Chmielik E, Decker T, Fend F, Kovács A, van Diest PJ, Ellis IO, Rakha E, Tot T, European Working Group For Breast Screening Pathology. Cserni G, et al. Among authors: foschini mp. Cancers (Basel). 2021 Nov 14;13(22):5694. doi: 10.3390/cancers13225694. Cancers (Basel). 2021. PMID: 34830849 Free PMC article. Review.
Invasion in breast lesions: the role of the epithelial-stroma barrier.
Rakha EA, Miligy IM, Gorringe KL, Toss MS, Green AR, Fox SB, Schmitt FC, Tan PH, Tse GM, Badve S, Decker T, Vincent-Salomon A, Dabbs DJ, Foschini MP, Moreno F, Wentao Y, Geyer FC, Reis-Filho JS, Pinder SE, Lakhani SR, Ellis IO. Rakha EA, et al. Among authors: foschini mp. Histopathology. 2018 Jun;72(7):1075-1083. doi: 10.1111/his.13446. Epub 2018 Feb 13. Histopathology. 2018. PMID: 29197112 Free article. Review.
Immunotherapy in head and neck cancer: evidence and perspectives.
Tosoni A, Franceschi E, Pasquini E, Lanese A, Donini E, Foschini MP, Dall'Olio D, Brandes AA. Tosoni A, et al. Among authors: foschini mp. Immunotherapy. 2017 Dec;9(16):1351-1358. doi: 10.2217/imt-2017-0125. Immunotherapy. 2017. PMID: 29185392 Review.
266 results